ZW30441
ZW30441 is a METTL3 PROTAC degrader with a DC50 value of 0.44 µM. ZW30441 binds CRBN and induces ubiquitination and degradation of METTL3 through the ubiquitin-proteasome system. ZW30441 also induces co-degradation of METTL14 with a DC50 value of 0.13 µM. ZW30441 exhibits antitumor activity against acute myeloid leukemia.
(Pink: METTL3-14 ligand (HY-115717); Blue: Cereblon ligand (HY-163233); Black: linker).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3095159-68-2
- 화학식: C53H71F2N11O5
- 분자량:980.20
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
IC50 & Target
[1]|
Cereblon |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MV4-11 | DC50 |
0.44 μM
|
Degradation of METTL3 in human MV4-11 AML cells after 24 hrs incubation with ZW30441 assessed by immunoblotting.
Degradation of METTL3 in human MV4-11 AML cells after 24 hrs incubation with ZW30441 assessed by immunoblotting.
|
41245600 |
| MV4-11 | DC50 |
0.13 μM
|
Degradation of METTL14 in human MV4-11 AML cells after 24 hrs incubation with ZW30441 assessed by immunoblotting.
Degradation of METTL14 in human MV4-11 AML cells after 24 hrs incubation with ZW30441 assessed by immunoblotting.
|
41245600 |
| MOLM-13 | EC50 |
1.02 μM
|
Suppression of viability in human MOLM13 AML cells after 72 hrs incubation with ZW30441.
Suppression of viability in human MOLM13 AML cells after 72 hrs incubation with ZW30441.
|
41245600 |
| MV4-11 | EC50 |
2.14 μM
|
Suppression of viability in human MV4-11 AML cells after 72 hrs incubation with ZW30441.
Suppression of viability in human MV4-11 AML cells after 72 hrs incubation with ZW30441.
|
41245600 |
In Vitro
ZW30441 (72 h) inhibits the growth of MOLM13 and MV4-11 AML cells; compared with STM2457 and UZH2, it shows comparable inhibitory effect on MOLM13 and stronger antiproliferative effect on MV4-11[1].
ZW30441 (0.05-2.0 µM; 24 h) degrades METTL3 and METTL14 in MV4-11 cells in a dose-dependent manner, with DC50 values of 0.44 µM and 0.13 µM, respectively[1].
ZW30441 (1 µM; 0-24 h) degrades METTL3 and METTL14 in MV4-11 cells in a time-dependent manner, with half-lives of 9.0 and 8.0 h, respectively[1].
ZW30441 (1 µM; 20 h exposure; 24 h washout) maintains METTL3/METTL14 degradation for approximately 24 h after washout in MV4-11 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MV4-11 AML cells
-
Concentration:0.05, 0.1, 0.25, 0.5, 1.0, 2.0 µM
-
Incubation Time:24 h
-
Result:Degraded METTL3 and METTL14 in a dose-dependent manner, with DC50 values of 0.44 µM and 0.13 µM, respectively.
-
Cell Line:MV4-11 AML cells
-
Concentration:1 µM
-
Incubation Time:0-24 h
-
Result:Induced gradual degradation of METTL3 and METTL14, with half-lives of 9.0 h and 8.0 h, respectively; maximum degradation was observed at 20 h.
-
Cell Line:MV4-11 AML cells
-
Concentration:1 µM
-
Incubation Time:20 h exposure; washout 24 h
-
Result:Degradation of the METTL3-METTL14 complex lasted for approximately 24 h after removal from the culture media.
-
Cell Line:HEK293T cells
-
Concentration:Bortezomib 0.1 µM or MG132 1 µM (2 h pretreatment); pomalidomide 10 µM; ZW30441 2.5 µM
-
Incubation Time:2 h pretreatment (bortezomib/MG132)
-
Result:Proteasome inhibitors bortezomib and MG132 effectively blocked METTL3 degradation.
Pomalidomide pretreatment significantly reduced degradation activity against METTL3.
Chemical Information
-
CAS No. 3095159-68-2
-
분자량 980.20
-
화학식 C53H71F2N11O5
-
SMILES
FC1=CC(N2CC3(CCN(C4=NC=NC(NCCCCCCCCCC(N5CCN(C6=CC7=C(C(N(C8C(NC(CC8)=O)=O)C7)=O)C=C6)CC5)=O)=C4)CC3)NC(C2)=O)=C(F)C=C1CN9CCC(C)(C)CC9
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)